Search
Ranosidenib
go.drugbank.com/drugs/DB21727InvestigationalRanosidenib has a monoisotopic molecular weight of 453.12 Da. … Ranosidenib is a small molecule drug. Ranosidenib is under investigation in clinical trial NCT06387069 (A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia).
CoVac-1
go.drugbank.com/drugs/DB16429InvestigationalSponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein[A226588].
Imalumab
go.drugbank.com/drugs/DB15558InvestigationalImalumab is under investigation in clinical trial NCT02540356 (Phase 1/2a Two-arm Dose-escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer).
Porphobilinogen
go.drugbank.com/drugs/DB02272ExperimentalPorphobilinogen is a pyrrole involved in porphyrin metabolism. It is generated by the enzyme ALA dehydratase, and converted into hydroxymethyl bilane by the enzyme porphobilinogen deaminase.
Canosimibe
go.drugbank.com/drugs/DB19723InvestigationalCanosimibe has a monoisotopic molecular weight of 809.43 Da. … Canosimibe is a small molecule drug.
Irampanel
go.drugbank.com/drugs/DB21123InvestigationalIrampanel has a monoisotopic molecular weight of 309.15 Da. … Irampanel is a small molecule drug.
Salacetamide
go.drugbank.com/drugs/DB20217InvestigationalSalacetamide has a monoisotopic molecular weight of 179.06 Da. … Salacetamide is a small molecule drug.
Aftobetin
go.drugbank.com/drugs/DB20425InvestigationalAftobetin has a monoisotopic molecular weight of 452.23 Da. … Aftobetin is a small molecule drug.
Rintodestrant
go.drugbank.com/drugs/DB21472InvestigationalRintodestrant has a monoisotopic molecular weight of 462.09 Da. … Rintodestrant is a small molecule drug.
Itruvone
go.drugbank.com/drugs/DB21543InvestigationalItruvone has a monoisotopic molecular weight of 296.21 Da. … Itruvone is a small molecule drug. Itruvone is under investigation in clinical trial NCT02322086 (A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10).